Indoco Remedies Limited
NSE:INDOCO.NS
307.9 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 18,172.9 | 16,400.5 | 15,037.374 | 12,186.078 | 10,799.754 | 9,420.811 | 10,176.712 | 10,967.707 | 10,037.572 | 8,569.537 | 7,326.091 | 6,303.962 | 5,687.725 | 4,835.573 | 3,982.848 | 2,626.847 | 0 | 3,259.867 | 2,434.265 | 1,941.453 |
| Cost of Revenue
| 10,129.9 | 5,212.9 | 4,637.656 | 3,596.41 | 3,350.699 | 3,236.292 | 3,510.189 | 3,859.883 | 3,715.071 | 3,004.422 | 2,719.821 | 2,619.631 | 2,875.863 | 2,131.442 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 8,043 | 11,187.6 | 10,399.718 | 8,589.668 | 7,449.055 | 6,184.519 | 6,666.523 | 7,107.824 | 6,322.501 | 5,565.115 | 4,606.27 | 3,684.331 | 2,811.862 | 2,704.131 | 3,982.848 | 2,626.847 | 0 | 3,259.867 | 2,434.265 | 1,941.453 |
| Gross Profit Ratio
| 0.443 | 0.682 | 0.692 | 0.705 | 0.69 | 0.656 | 0.655 | 0.648 | 0.63 | 0.649 | 0.629 | 0.584 | 0.494 | 0.559 | 1 | 1 | 0 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 971.6 | 809.7 | 746.419 | 597.036 | 497.02 | 515.155 | 534.898 | 517.104 | 431.787 | 216.715 | 144.286 | 129.024 | 108.032 | 93.415 | 102.226 | 71.832 | 0 | 54.465 | 0 | 0 |
| General & Administrative Expenses
| 367.6 | 2,646.754 | 125.134 | 167.295 | 295.503 | 153.906 | 125.484 | 132.704 | 42.686 | 1,434.994 | 108.098 | 63.493 | 544.052 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 1,751.249 | 715.664 | 1,387.215 | 1,120.96 | 1,224.851 | 932.205 | 1,007.172 | 1,002.971 | 284.116 | 229.356 | 709.036 | 537.634 | 340.637 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5,547 | 3,362.418 | 1,512.349 | 1,288.255 | 1,520.354 | 1,086.111 | 1,132.656 | 1,135.675 | 326.802 | 1,664.35 | 2,615.813 | 2,073.06 | 884.689 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 98.5 | 8,223 | 5,952.329 | 5,129.822 | 4,948.795 | 34.885 | 4.832 | 7.077 | 4,426.601 | 4,153.666 | 3,556.779 | 2,857.64 | -2.893 | 1,969.981 | 3,168.002 | 1,994.332 | 0 | 2,476.898 | 1,883.536 | 1,494.046 |
| Operating Expenses
| 6,518.6 | 9,032.7 | 8,211.097 | 7,015.113 | 6,966.169 | 6,288.443 | 6,021.887 | 6,152.891 | 5,185.19 | 4,370.381 | 3,701.065 | 2,986.664 | 2,147.485 | 2,063.396 | 3,270.228 | 2,066.164 | 0 | 2,531.363 | 1,883.536 | 1,494.046 |
| Operating Income
| 1,524.4 | 2,178.3 | 2,553.254 | 1,681.363 | 619.085 | -103.924 | 644.636 | 954.933 | 1,137.311 | 1,194.734 | 905.205 | 697.667 | 664.377 | 640.735 | 712.62 | 560.683 | 0 | 728.504 | 550.729 | 447.407 |
| Operating Income Ratio
| 0.084 | 0.133 | 0.17 | 0.138 | 0.057 | -0.011 | 0.063 | 0.087 | 0.113 | 0.139 | 0.124 | 0.111 | 0.117 | 0.133 | 0.179 | 0.213 | 0 | 0.223 | 0.226 | 0.23 |
| Total Other Income Expenses Net
| -166.4 | -250.3 | -187.542 | -361.392 | -333.362 | 10.802 | -160.654 | -45.574 | -131.51 | -99.269 | -182.04 | -213.968 | -151.72 | -74.89 | -281.347 | -240.254 | 0 | -262.37 | -121.169 | -80.927 |
| Income Before Tax
| 1,358 | 1,928 | 2,365.712 | 1,319.971 | 285.723 | -93.122 | 483.982 | 909.359 | 1,005.801 | 1,095.465 | 723.165 | 483.699 | 512.657 | 565.845 | 431.273 | 320.429 | 0 | 466.134 | 429.56 | 366.48 |
| Income Before Tax Ratio
| 0.075 | 0.118 | 0.157 | 0.108 | 0.026 | -0.01 | 0.048 | 0.083 | 0.1 | 0.128 | 0.099 | 0.077 | 0.09 | 0.117 | 0.108 | 0.122 | 0 | 0.143 | 0.176 | 0.189 |
| Income Tax Expense
| 387.9 | 505.5 | 817.717 | 389.516 | 44.549 | -64.082 | 72.372 | 138.749 | 175.998 | 267.34 | 142.835 | 57.114 | 49.233 | 54.667 | 10.352 | 19.462 | 0 | 45.752 | 114.652 | 116.057 |
| Net Income
| 984.601 | 1,422.5 | 1,548 | 930.455 | 241.174 | -29.04 | 411.61 | 770.61 | 829.803 | 828.125 | 579.812 | 426.585 | 463.424 | 511.178 | 420.921 | 300.967 | 0 | 420.382 | 314.908 | 250.423 |
| Net Income Ratio
| 0.054 | 0.087 | 0.103 | 0.076 | 0.022 | -0.003 | 0.04 | 0.07 | 0.083 | 0.097 | 0.079 | 0.068 | 0.081 | 0.106 | 0.106 | 0.115 | 0 | 0.129 | 0.129 | 0.129 |
| EPS
| 10.53 | 15.44 | 16.8 | 10.1 | 2.62 | -0.32 | 4.47 | 8.36 | 8.89 | 8.99 | 6.29 | 4.64 | 5.03 | 5.55 | 4.57 | 3.41 | 0 | 4.69 | 3.2 | 3.27 |
| EPS Diluted
| 10.51 | 15.42 | 16.8 | 10.1 | 2.62 | -0.32 | 4.47 | 8.36 | 8.89 | 8.99 | 6.29 | 4.64 | 5.03 | 5.55 | 4.57 | 3.41 | 0 | 4.69 | 3.2 | 3.27 |
| EBITDA
| 2,443.1 | 2,884.4 | 3,325.343 | 2,412.614 | 1,327.244 | 821.124 | 1,389.88 | 1,691.334 | 1,711.219 | 1,633.715 | 1,213.958 | 934.946 | 869.309 | 724.408 | 833.625 | 672.237 | 0 | 818.757 | 613.957 | 490.818 |
| EBITDA Ratio
| 0.134 | 0.176 | 0.221 | 0.198 | 0.123 | 0.087 | 0.137 | 0.154 | 0.17 | 0.191 | 0.166 | 0.148 | 0.153 | 0.15 | 0.209 | 0.256 | 0 | 0.251 | 0.252 | 0.253 |